Exclusively, the Ventana PD-L1 SP142 assay is approved by US Food and Drug Administration (FDA) as well as European Medicines Agency (EMA) for testing PD-L1 expression on tumour cells (TC) and immune cells (IC) [28]. The gene discussed is CD274; the disease is neoplasm.